Literature DB >> 31225984

Creating a Synthetic Clinical Trial: Comparative Effectiveness Analyses Using an Electronic Medical Record.

Marjorie G Zauderer1,2, Aleksandr Grigorenko1, Paul May1, Nicholas Kastango1, Isaac Wagner1, Aryeh Caroline1, Mark G Kris1,2.   

Abstract

PURPOSE: Electronic medical records (EMRs) are a vast resource of potentially mineable data that can be used to complement and extend clinical trials. Extracting and analyzing EMR data are impeded by technical complexities associated with large, multiformat databases. We sought to develop and validate a framework that would overcome the difficulties associated with EMR data and create a simple, portable, and expandable system to better use this resource.
MATERIALS AND METHODS: An Internet-accessible program was developed in Python that applied user-defined criteria to identify and extract patient data from Memorial Sloan Kettering databases. A Worker Application composed of individual modules was developed to identify each patient's functional status, smoking status, and treatment classification. The validity of this approach was tested by identifying, extracting, and analyzing data from a patient cohort that paralleled a practice-changing, prospective, randomized phase III clinical trial performed at a different institution. We called this a synthetic clinical trial.
RESULTS: Our synthetic clinical trial identified and extracted data on a cohort of 281 patients with lung cancer who matched inclusion criteria and received their first treatment between October 2003 and July 2010. The data extraction modules were precise and accurate, with F-measures greater than 0.98. Results were similar in directionality and magnitude to the chosen comparator clinical trial.
CONCLUSION: Our framework offers an accurate and user-friendly interface for identifying and extracting EMR data that can be used to create synthetic clinical trials. Additional studies are needed to validate this approach in other patient cohorts, replicate our findings, and leverage this methodology to improve patient care and accelerate drug development.

Entities:  

Mesh:

Year:  2019        PMID: 31225984      PMCID: PMC6874028          DOI: 10.1200/CCI.19.00037

Source DB:  PubMed          Journal:  JCO Clin Cancer Inform        ISSN: 2473-4276


  16 in total

Review 1.  Extracting information from textual documents in the electronic health record: a review of recent research.

Authors:  S M Meystre; G K Savova; K C Kipper-Schuler; J F Hurdle
Journal:  Yearb Med Inform       Date:  2008

2.  An electronic practice-based network for observational comparative effectiveness research.

Authors:  Wilson D Pace; Maribel Cifuentes; Robert J Valuck; Elizabeth W Staton; Elias C Brandt; David R West
Journal:  Ann Intern Med       Date:  2009-07-28       Impact factor: 25.391

3.  When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

Authors:  Jessica M Franklin; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2017-09-25       Impact factor: 6.875

4.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

5.  Extracting data from electronic medical records: validation of a natural language processing program to assess prostate biopsy results.

Authors:  Anil A Thomas; Chengyi Zheng; Howard Jung; Allen Chang; Brian Kim; Joy Gelfond; Jeff Slezak; Kim Porter; Steven J Jacobsen; Gary W Chien
Journal:  World J Urol       Date:  2013-02-17       Impact factor: 4.226

6.  Carboplatin and gemcitabine in first-line treatment of elderly patients with advanced non-small cell lung cancer: data from a retrospective study.

Authors:  G Genestreti; N Giovannini; M Frizziero; M Maglie; S Sanna; S Cingarlini; A M Molino; S Piciucchi; G L Cetto; A Santo
Journal:  J Chemother       Date:  2011-08       Impact factor: 1.714

7.  Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: an institutional report.

Authors:  G F Samelis; K A Ekmektzoglou; A Tsiakou; S Giannakaki; D Georgoulias; K Christophilopoulos
Journal:  J BUON       Date:  2011 Oct-Dec       Impact factor: 2.533

8.  Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm.

Authors:  Justin A Strauss; Chun R Chao; Marilyn L Kwan; Syed A Ahmed; Joanne E Schottinger; Virginia P Quinn
Journal:  J Am Med Inform Assoc       Date:  2012-07-21       Impact factor: 4.497

9.  Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?

Authors:  Sajan Khosla; Robert White; Jesús Medina; Mario Ouwens; Cathy Emmas; Tim Koder; Gary Male; Sandra Leonard
Journal:  F1000Res       Date:  2018-01-25

10.  Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable.

Authors:  Nancy A Dreyer
Journal:  Ther Innov Regul Sci       Date:  2018-03-19       Impact factor: 1.778

View more
  1 in total

1.  Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective.

Authors:  Daniel L Hertz; Lisa M McShane; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2022-03-24       Impact factor: 50.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.